Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06763432 · ClinicalTrials.gov registry record
Positive Fit to Colonoscopy: Closing the Gap
A clinical trial of Colorectal Cancer Screening, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT06763432: Recruiting study of Colorectal Cancer Screening, sponsored by Massachusetts General Hospital.
NCT06763432 is a study of Colorectal Cancer Screening that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 45 participants, below the 5,880-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06763432, a study of Colorectal Cancer Screening, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this proposal are to: (1) identify patient- and system-level determinants of diagnostic colonoscopy after positive FIT; (2) identify patient- and system-level equity-driven implementation strategies for diagnostic colonoscopy after positive FIT matched to determinants; and (3) pilot test patient- and systems-level implementation strategies to increase rate of colonoscopy after positive FIT and determine feasibility and acceptability of strategies using mixed methods
Primary Outcome
For our primary outcome, participants will be asked to rate the acceptability and feasibility of implementation strategies using a previously validated instrument, which the investigator previously used with CHC staff. This tool has demonstrated good internal consistency reliability (0.85 for acceptability and 0.89 for feasibility) and similarly good test-retest reliability (correlations: acceptability- 0.80; feasibility - 0.88) and validity in a known groups analysis. There are no cut off numbe
Conditions Studied
Study Locations (1)
Massachusetts
- Codman Square Health Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-06-16 |
| Est. Completion | 2029-08-31 |
What NCT06763432 shows while recruiting
NCT06763432 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 5,880-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 0 interventions.
NCT06763432 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06763432 about?
NCT06763432 is a clinical study titled "Positive Fit to Colonoscopy: Closing the Gap". The goals of this proposal are to: (1) identify patient- and system-level determinants of diagnostic colonoscopy after positive FIT; (2) identify patient- and system-level equity-driven implementation strategies for diagnostic colonoscopy after positive FIT matched to determinants; and (3) pilot tes...
What is the current status of trial NCT06763432?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2025-06-16. Estimated completion is 2029-08-31.
What conditions does trial NCT06763432 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening.
Who is sponsoring clinical trial NCT06763432?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06763432 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06763432's enrollment target sits among peer trials
45 18th of 19 higher than 2 of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
RECRUITING · Phase 4
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI